LB313 – issue menu
Access your pdf edition of LB magazine – issue 313
We are providing more options for you to access your copy of Legal Business. Please see below for links to a limited version followed by a complete version. The complete version is only accessible to subscribers. Please make sure you are logged into the site to see the link. Limited version
Global London 2023 – US firms thrive even as the deal market starts to cool
Sponsored by
Global London 2023 Main table
A pdf version of the main table is also available.
The Last Word: London manifesto
‘We already have a strong European offering and our current expansion plans are centred on partner-level and team hires that support us in providing our clients with the best possible industry and subject matter experts.’ Tamara Box, Reed Smith To mark the launch of our 2023 Global London analysis, we ask senior figures at leading …
Disputes Yearbook 2023: Bench strength revisited
Disputes Yearbook 2023 – online PDF
Please see below for a link to an online pdf of the Disputes Yearbook 2023. This will only be accessible to subscribers. Please make sure you are logged into the site to see the link. Legal Business subscribers will be receiving their physical copies of the Disputes Yearbook with Legal Business circulation.
International round-up: Morgan Lewis opens second German office as Taylor Wessing welcomes new Ireland partners
Morgan Lewis is to open a Munich office with a team of 20 lawyers from Shearman & Sterling, in what are the latest departures from Shearman as its merger talks with Hogan Lovells collapsed. Morgan Lewis’s new transactional and regulatory team will focus on M&A, private equity, finance and tax. Partners Florian Harder, Florian Zielger …
‘We share strategy, values and corporate culture’: Taylor Wessing seals strategic alliance with Spain’s ECIJA
Taylor Wessing is expanding its global TMT offering in Spain and Latin America through a new strategic alliance with Madrid-based ECIJA. Announced today (7 March), the alliance ‘is in response to the continued investment, innovation and expansion of TMT and life sciences companies worldwide’.
LB312 – issue menu
